It was inspiring to find that the expression of CNOT family (CNOT2 and CNOT9) and SHMT1 was highly correlated with the prognosis of thymoma: Patients with lower expression of these genes at transcription level had poor relapse‐free survival (RFS) probability (Fig. S9). The gene discussed is CNOT2; the disease is thymoma.